SEC Filing Analysis: INCYTE CORP (INCY)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Executive Vice President & Chief Scientific Officer of Incyte sold approximately $555k worth of stock in a pre-scheduled transaction under a 10b5-1 plan.
• Market Impact: The transaction is immaterial relative to the company's market capitalization and is unlikely to have a significant market impact.

Company Information

Field	Value
Company	INCYTE CORP
Ticker Symbol	INCY
CIK	0000879169
Industry	Commercial Physical & Biological Research

Insider Information

Field	Value
Name	Mayes Patrick A
CIK	0002079962
Title/Position	EVP & Chief Scientific Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-10
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	5,808
Price Per Share	$95.53 (Weighted Average)
Total Value	$554,859.24
Shares Owned After	60,011
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$554,859.24
% of Market Cap	0.0027%
Shares Transacted	5,808
% of Shares Outstanding	0.0030%
Post-Transaction Ownership	60,011 shares (0.031% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market capitalization of $20.45 billion, this transaction of ~$555k is negligible and represents a routine portfolio adjustment for the executive.
• Ownership Concentration: The insider's post-transaction ownership of 60,011 shares (including 59,858 unvested RSUs) constitutes a very small fraction (0.031%) of the total shares outstanding, indicating low ownership concentration.
• Transaction Significance: The sale represents less than 0.01% of both market cap and shares outstanding, placing it firmly in the 'Low' significance category. It also constitutes a minor portion (~8.8%) of the insider's prior holdings.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is small in value and was executed under a pre-arranged 10b5-1 trading plan, which negates any inference of new negative information. Such sales are common for executive compensation and liquidity purposes.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction size is too small to impact trading volume.
• Sentiment Indicator: Neutral. The pre-scheduled nature of the sale provides no new information to influence market sentiment.

Additional Context

Transaction Notes

• Special Circumstances: The filing indicates this transaction was made pursuant to a Rule 10b5-1 trading plan, which allows insiders to set up a pre-determined schedule for selling stocks at a time when they are not in possession of material non-public information.